1 April 2025 false No description of principal activity Taxfiler 2024.6 10889267 business:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 10889267 2025-03-31 10889267 2025-04-01 2026-03-31 10889267 business:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 10889267 business:FilletedAccounts 2025-04-01 2026-03-31 10889267 2026-03-31 10889267 business:Director1 2025-04-01 2026-03-31 10889267 2025-03-31 10889267 core:WithinOneYear 2026-03-31 10889267 core:WithinOneYear 2025-03-31 10889267 core:ShareCapital core:PreviouslyStatedAmount 2026-03-31 10889267 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 10889267 core:PreviouslyStatedAmount 2026-03-31 10889267 core:PreviouslyStatedAmount 2025-03-31 10889267 business:SmallEntities 2025-04-01 2026-03-31 10889267 countries:EnglandWales 2025-04-01 2026-03-31 10889267 core:ComputerEquipment 2025-04-01 2026-03-31 10889267 core:ComputerEquipment 2025-03-31 10889267 core:ComputerEquipment 2026-03-31 10889267 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 10889267 (England and Wales)
AMZ Mpharm Ltd Unaudited accounts for the year ended 31 March 2026
AMZ Mpharm Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
AMZ Mpharm Ltd Company Information for the year ended 31 March 2026
Director
Muzamal Akram
Company Number
10889267 (England and Wales)
Accountants
PRIME ACCOUNTANTS 10 LOCKWOOD HOUSE LOCKWOOD PARK HUDDERSFIELD HD4 6EN
- 3 -
AMZ Mpharm Ltd Statement of financial position as at 31 March 2026
2026
2025
Notes
£
£
Current assets
Debtors
5
100
-
Cash at bank and in hand
2,737
103,392
2,837
103,392
Creditors: amounts falling due within one year
6
(2,836)
(103,391)
Net current assets
1
1
Net assets
1
1
Capital and reserves
Called up share capital
1
1
Shareholders' funds
1
1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 12 August 2026 and were signed on its behalf by
Muzamal Akram Director Company Registration No. 10889267
- 4 -
AMZ Mpharm Ltd Notes to the Accounts for the year ended 31 March 2026
1
Statutory information
AMZ Mpharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 10889267.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% straight line
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 April 2025
3,500
At 31 March 2026
3,500
Depreciation
At 1 April 2025
3,500
At 31 March 2026
3,500
Net book value
At 31 March 2026
-
5
Debtors
2026
2025
£
£
Amounts falling due within one year
Other debtors
100
-
- 5 -
AMZ Mpharm Ltd Notes to the Accounts for the year ended 31 March 2026
6
Creditors: amounts falling due within one year
2026
2025
£
£
Taxes and social security
85
1,196
Loans from directors
2,751
102,195
2,836
103,391
7
Average number of employees
During the year the average number of employees was 3 (2025: 3).
- 6 -